
News|Articles|January 1, 2002
Kineret (Anakinra) AMGEN
Biologic: First IL-1 receptor blocker for moderate to severe rheumatoid arthritis
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement























